back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-11-30 Tx date 2018-11-21 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
1,125,000 | |
| Filed 2018-07-13 Tx date 2015-11-26 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
300,000 | |
| Filed 2018-07-13 Tx date 2016-06-09 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-07-13 Tx date 2016-12-07 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+1,846,000 vol |
1,846,000 | |
| Filed 2018-07-13 Tx date 2016-12-21 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,384,500 vol |
461,500 | |
| Filed 2018-07-13 Tx date 2016-09-14 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
800,000 | |
| Filed 2018-07-13 Tx date 2016-11-21 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,800,000 | |
| Filed 2018-07-13 Tx date 2016-12-21 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-225,000 vol |
1,575,000 | |
| Filed 2018-07-13 Tx date 2016-12-21 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-375,000 vol |
1,200,000 | |
| Filed 2018-07-13 Tx date 2016-12-21 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-750,000 vol |
450,000 | |
| Filed 2018-07-13 Tx date 2017-03-01 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-250,000 vol |
200,000 | |
| Filed 2018-07-13 Tx date 2017-04-20 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
-250,000 vol |
||
| Filed 2018-07-13 Tx date 2016-06-09 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-07-13 Tx date 2017-04-20 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
450,000 | |
| Filed 2018-07-13 Tx date 2017-12-21 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-225,000 vol |
||
| Filed 2018-07-13 Tx date 2017-12-21 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-225,000 vol |
||
| Filed 2018-07-13 Tx date 2017-12-21 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-375,000 vol |
||
| Filed 2018-07-13 Tx date 2017-12-21 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-375,000 vol |
||
| Filed 2018-07-13 Tx date 2017-12-21 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-750,000 vol |
||
| Filed 2018-07-13 Tx date 2017-12-21 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-750,000 vol |
||
| Filed 2018-07-13 Tx date 2018-04-19 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
525,000 | |
| Filed 2018-07-13 Tx date 2016-06-09 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-07-13 Tx date 2016-12-07 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,846,000 vol |
1,846,000 | |
| Filed 2018-07-13 Tx date 2016-12-21 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-1,384,500 vol |
461,500 | |
| Filed 2018-07-13 Tx date 2017-04-20 |
$VP
Vodis Pharmaceuticals Inc. |
Ovagemov, Plamen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
-250,000 vol |